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Background: Increased consumption of omega-3 polyunsaturated fatty acids (ω3-PUFAs)
from ﬁsh oil (FO) may have cardioprotective effects during ischemia/reperfusion, hypertro-
phy, and heart failure (HF). The cardiac Na+/H+-exchanger (NHE-1) is a key mediator for
these detrimental cardiac conditions. Consequently, chronic NHE-1 inhibition appears to
be a promising pharmacological tool for prevention and treatment. Acute application of
the FO ω3-PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) inhibit the
NHE-1 in isolated cardiomyocytes.We studied the effects of a diet enriched with ω3-PUFAs
on the NHE-1 activity in healthy rabbits and in a rabbit model of HF induced by volume-
and pressure-overload. Methods: Rabbits were allocated to four groups. The ﬁrst two
groups consisted of healthy rabbits, which were fed either a diet containing 1.25% (w/w)
FO (ω3-PUFAs), or 1.25% high-oleic sunﬂower oil (ω9-MUFAs) as control. The second two
groups were also allocated to either a diet containing ω3-PUFAs or ω9-MUFAs, but under-
went volume- and pressure-overload to induce HF. Ventricular myocytes were isolated by
enzymatic dissociation and used for intracellular pH (pHi) and patch-clamp measurements.
NHE-1 activity was measured in HEPES-buffered conditions as recovery rate from acidosis
due to ammonium prepulses. Results: In healthy rabbits, NHE-1 activity in ω9-MUFAs and
ω3-PUFAs myocytes was not signiﬁcantly different. Volume- and pressure-overload in rab-
bits increased the NHE-1 activity in ω9-MUFAs myocytes, but not in ω3-PUFAs myocytes,
resulting in a signiﬁcantly lower NHE-1 activity in myocytes of ω3-PUFA fed HF rabbits.
The susceptibility to induced delayed afterdepolarizations (DADs), a cellular mechanism of
arrhythmias, was lower in myocytes of HF animals fed ω3-PUFAs compared tomyocytes of
HF animals fed ω9-MUFAs. In our rabbit HF model, the degree of hypertrophy was similar
in the ω3-PUFAs group compared to the ω9-MUFAs group. Conclusion:Dietary ω3-PUFAs
from FO suppress upregulation of the NHE-1 activity and lower the incidence of DADs in
our rabbit model of volume- and pressure-overload.
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INTRODUCTION
Increased consumption of omega-3 polyunsaturated fatty acids
(ω3-PUFAs) from ﬁsh oil (FO) may exert beneﬁcial effects on
the heart, as evidenced by a decreased risk of ischemic heart dis-
ease, sudden cardiac death (Burr et al., 1989; GISSI-Prevenzione
Investigators, 1999), and a lower incidence of heart failure (HF;
Mozaffarian et al., 2005; Yamagishi et al., 2008; Levitan et al.,
2009; Chen et al., 2011). Various mechanisms for the observed
beneﬁcial effects of ω3-PUFAs have been proposed, i.e., decrease
in blood pressure, heart rate, and platelet aggregation, anti-
inﬂammatory (Kris-Etherton et al., 2002), and ionic remodeling
resulting in a decrease of cardiac arrhythmias (den Ruijter et al.,
2007; London et al., 2007), but the exact mechanisms are not fully
known.
Evidence is increasing that the Na+/H+-exchanger isoform-
1 (NHE-1) plays a crucial role in ischemia/reperfusion injury,
hypertrophy, and HF (for reviews, see Cingolani and Ennis, 2007;
Fliegel, 2009; Vaughan-Jones et al., 2009). The NHE-1 is an inte-
gral membrane protein that extrudes one H+ ion in exchange for
one Na+ ion in an electroneutral fashion. Its activity is high at
acidic intracellular pH (pHi) conditions and gradually declines
to zero when its set-point pHi value, just above resting pHi value
(∼pH 7.2) is reached. At resting pHi acid extrusion through NHE-
1 activity equals acid loading activity and proton production rate,
thereby maintaining pHi at neutral values. This, however, is at the
expense of a continuous Na+ inﬂux. Thus, the NHE-1 has also
a major role in intracellular Na+ ([Na+]i) loading (Baartscheer
and van Borren, 2008; Fliegel, 2009; Vaughan-Jones et al., 2009).
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This [Na+]i loading effect is of importance especially under con-
ditions where NHE-1 activity is high such as ischemia/reperfusion
(Ayoub et al., 2003; Bak and Ingwall, 2003; van Borren et al., 2004),
hypertrophy, and HF (Baartscheer et al., 2003a; Chahine et al.,
2005; van Borren et al., 2006; Nakamura et al., 2008). In these
conditions, the [Na+]i loading via the NHE-1 shifts the driving
force of Na+/Ca2+ exchange into the direction of less forward
and increased reversed modes, which consequently will elevate
intracellular Ca2+ ([Ca2+]i) concentration with potentially detri-
mental cardiac effects. Consequently, a reduction of Na+ inﬂux
via NHE-1 inhibition appears to be a promising pharmacological
tool for the treatment of ischemia/reperfusion, hypertrophy, and
HF (Baartscheer et al., 2005; Cingolani and Ennis, 2007).
Goel et al. (2002) have shown that acute application of the ω3-
PUFA eicosapentaenoic acid (EPA) as well as docosahexaenoic
acid (DHA) inhibited the NHE-1 in isolated cardiomyocytes.
Considering the importance of NHE-1 in ischemia/reperfusion
injury, hypertrophy, and HF, NHE-1 inhibition may be the crucial
link between FO and the well-known cardioprotective effects of
ω3-PUFAs. In addition, it suggests thatω3-PUFAsmay be an alter-
native or a complementary approach to existing NHE-1 inhibiting
pharmacological drugs. In the present study we assessed the effects
of long term treatment with ω3-PUFAs on NHE-1 in healthy rab-
bits and in a rabbit model of volume- and pressure-overload. To
speciﬁcally address the effects of a diet rich in ω3-PUFAs from FO
onNHE-1 in our study,we chose to use theω9-MUFAs as a control
fatty acids. These fatty are more abundantly present in the human
diet and do not alter cardiac electrophysiology (den Ruijter et al.,
2008). Therefore, rabbits were fed a diet rich in either ω3-PUFAs
from FO or omega-9 monounsaturated fatty acids (ω9-MUFAs)
from high-oleic sunﬂower oil (HOSF) as control.
MATERIALS AND METHODS
ANIMALS AND DIET
All experiments were carried out in accordance with guidelines of
the local institutional animal care and use committee. In addition,
the investigation conforms the Guide for the Care and Use of Lab-
oratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996).
Male New ZealandWhite rabbits (4months old) received a diet
(150 g/day; Research Diet Services, Wijk bij Duurstede, Nether-
lands) supplemented with either 1.25% (w/w) FO or 1.25% HOSF
as control. Food consumption of every rabbit was measured and
average food intake did not differ between FO and HOSF fed ani-
mals (data not shown). In the HF model, diet started 1week before
the surgical procedures to induce HF (see below). Lipids from the
diet and the left ventricular tissue were extracted with the method
of Folch et al. (1957). Table 1 summarizes the fatty acid composi-
tion of these diets. In short, the total PUFA content was higher in
the ω3-PUFAs diet due to a larger amount of both EPA and DHA.
Heart failure was induced by combined volume- and pressure-
overload in two sequential surgical procedures as described pre-
viously in detail (Vermeulen et al., 1994; Baartscheer et al., 2003a;
Verkerk et al., 2007). In short, volume overload was produced
by catheter-induced damage to the aortic valve until pulse pres-
sure was increased by about 100%. Three weeks later, pressure-
overload was created by abdominal aortic stenosis by ligation of
Table 1 | Fatty acid composition of ω9-MUFA and ω3-PUFA diets.
ω9-MUFA ω3-PUFA
SATURATED FATTYACIDS
Total 16.2 21.8
MONOUNSATURATED FATTYACIDS
Total 44.0 17.9
C18:1ω9 (oleic acid) 42.4 12.2
POLYUNSATURATED FATTYACIDS
Total 37.6 56.6
C18:2ω6 (LA) 30.5 26.8
C18:3ω3 (ALA) 6.85 7.12
C20:4ω6 (AA) 0.00 0.57
C20:5ω3 (EPA) 0.1 9.2
C22:6ω3 (DHA) 0.1 6.3
Other, unidentiﬁed fatty acids 2.2 3.6
Fatty acid composition expressed as percentage of total fatty acids. ω9-MUFA,
high-oleic sunﬂower oil; ω3-PUFA, ﬁsh oil; LA, linoleic acid; ALA, α-linolenic acid;
AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.
The sum of listed components is less than the totals indicated here, since not all
components were analyzed.
approximately 50%. After 3 weeks for the healthy animals and
after 4months for the HF animals, the rabbits were anesthetized
[(ketamine (50mg i.m.) and xylazine (10mg i.m.)], heparinized
(5000 IU), and killed by intravenous injection of pentobarbital
(240mg).
CELL PREPARATION
Single midmyocardial myocytes were isolated by enzymatic dis-
sociation from the most apical part of the left ventricular free
wall as described previously (de Groot et al., 2003). Small aliquots
of cell suspension were put in a recording chamber on the stage
of an inverted microscope. Myocytes were allowed to adhere for
5min after which superfusion with Tyrode’s solution was started.
Tyrode’s solution (36± 0.2˚C) contained (in mM): NaCl 140,
KCl 5.4, CaCl2 1.8, MgCl2 1.0, glucose 5.5, HEPES 5.0, pH 7.4
(NaOH). Quiescent rod-shaped cross-striated myocytes with a
smooth surface were selected for measurements.
INTRACELLULAR pH MEASUREMENTS
Intracellular pH (pHi) was measured in carboxy-seminaphthor-
hodaﬂuor-1 (SNARF-AM, Molecular Probes) loaded myocytes as
described previously (Baartscheer et al., 2003a; van Borren et al.,
2004). In short, myocytes were excited at 515 nm (75W Xenon
arc lamp) and dual wavelength emission of SNARF was recorded
at wavelengths of 580 nm (I 580) and 640 nm (I 640). A rectangular
adjustable slit ensured negligible background ﬂuorescence levels.
As shown in a typical example in Figure 1A, the I 580/I 640 ratio was
calibrated by a series of precisely set pH solutions that contained
140mM K+ instead of Na+ and the K+/H+ ionophore nigericin
(10μM; Sigma). Figure 1B shows the resulting calibration curve
were the 580/640 ratios were plot against the pHi.
Intrinsic buffering power
In general, activities of acid loaders or extruders are expressed as
the amount of acid or base extruded or loaded per second, the
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FIGURE 1 | (A,B) In vivo calibration curve of SNARF-AM.To determine
calibration curve myocytes were loaded with SNARF-AM and superfused
in presence op nigericin with several high K+ solutions at various pHo
values (A). When the external and internal K+ free concentrations are
equal, pHi is the same as pHo. The calibration curve (B) was obtained by
plotting the ratios (580/640) against the corresponding pHo. The red line
represents a Henderson–Hasselbalch ﬁt through these data, which
revealed a maximum ratio of 2.97 and a minimum ratio of 0.36 and a pK a
of 7.57. (C,D) Determination of the intrinsic sarcoplasmic buffer power (βi ).
Typical example of the “stepwise reduction in extracellular NH3/NH4+
approach” in a myocyte isolated from a healthy, ω3-PUFA fed animal (C),
and pHi–βi relationships of ω3-PUFA and ω9-MUFA myocytes of both
healthy rabbits (Ctrl) and the rabbits with heart failure (HF). (E)Typical
example and schematic explanation of an ammonium prepulse. (F)Typical
examples of effects of Na+-free conditions and cariporide on the acid load
recovery in HEPES-buffered conditions.
proton ﬂux (JH; Roos and Boron, 1981). Changes in pHi are not
linearly related to JH due to the presence of a pHi-dependent
intrinsic sarcoplasmic buffer power (βi). βi was determined by
the “stepwise reduction in extracellular NH3/NH4+ approach”
as described previously (Boyarsky et al., 1988), and shown in
the typical example of Figure 1C. With each stepwise decrease
in extracellular NH3/NH4+, the amount of protons delivered to
the cytoplasm (Δ[acid]i) was considered equal to the resultant
change in intracellular NH4+ concentration, which can be calcu-
lated from the observed pHi. ΔpHi was taken as the change in pHi
produced by the stepwise decrease in extracellular NH3/NH4+. βi
was then calculated as −Δ[acid]i/ΔpHi (Roos and Boron, 1981).
βi was assigned to the mean of the two pHi values used for its cal-
culation. Figure 1D shows the pHi–βi relationships of myocytes
isolated from ω3-PUFA and ω9-MUFA fed healthy rabbits and of
myocytes of ω3-PUFA and ω9-MUFA fed rabbits with model of
volume- and pressure-overload. The pHi–βi relationships did not
differ signiﬁcantly, indicating that neither the diets nor HF affect
the βi.
NHE-1 activity
Na+/H+-exchanger isoform-1 activity was measured in HEPES-
buffered conditions as recovery rate from acidosis due to ammo-
nium prepulses as described previously (van Borren et al., 2004).
Figure 1E shows a typical example and explanation of the pH
changes in response to an ammonium prepulse. In short, 20mM
NH4Cl (NH4+/NH3) was rapidly added to the Tyrode’s solution
resulting instantly in alkalinization of myocytes (Figure 1E, phase
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1), after which they slowly recovered from alkalization mainly
because of NH4+ inﬂux (Figure 1E, phase 2). After withdrawal of
NH4+/NH3 from the extracellular solutions all intracellularNH4+
is converted to NH3 which leaves the myocyte and the remaining
H+ acidiﬁes the sarcoplasm (Figure 1E, phase 3). Subsequently,
in HEPES-buffered solutions, the myocytes slowly recovered from
the acid load due to NHE-1 activity (Figure 1E, phase 4). The
recovery from acid load is Na+-dependent as well as blocked by
cariporide (10μM; Figure 1F), typical hallmarks of the NHE-1.
From the pHi traces we computed the dpHi/dt’s and multiplied
these with βi to arrive at JNHE-1.
CELLULAR ELECTROPHYSIOLOGY
Action potentials (APs) and delayed afterdepolarizations (DADs)
were recorded with the perforated patch-clamp technique using
an Axopatch 200B ampliﬁer (Molecular Devices, Sunnyvale, CA,
USA). Signals were low-pass ﬁltered with a cut-off frequency
of 2 kHz and digitized at 3 kHz. Data acquisition and analysis
were accomplished using custom software and potentials were
corrected for liquid junction potential (Barry and Lynch, 1991).
APs were elicited at 3Hz by 3-ms long, 1.2× threshold current
pulses through the patch pipette. We analyzed resting membrane
potential (RMP), maximal upstroke velocity (V max), AP ampli-
tude (APA), and AP duration at 20, 50, and 90% repolarization
(APD20, APD50, and APD90, respectively). Susceptibility to DADs
were evoked by a 3-Hz (10-s) rapid pacing episode followed by
an 8-s pause (tracing period) in the presence of norepinephrine
(100 nM, Centrafarm, Etten-Leur, The Netherlands). A DAD was
deﬁned as a temporary, short-lived deviation from (an otherwise
stable) RMP of more than 2mV. Data from ﬁve APs and ﬁve rapid
pacing episodewere averaged.Cellmembrane capacitance,an elec-
trophysiologicalmeasure of cell size,was estimated aswe described
previously in detail (Verkerk et al., 2004).
STATISTICS
Data are mean± SEM. Groups were compared using Two-Way
Repeated Measures ANOVA followed by pairwise comparison
using the Student–Newman–Keuls test, Fisher’s exact test, or
unpaired t -test. P < 0.05 is considered statistical signiﬁcant.
RESULTS
ω3-PUFA RICH DIET RESULTS IN ω3-PUFAs INCORPORATED IN THE
CELL MEMBRANE
The diet rich in ω3-PUFAs from FO resulted in a signiﬁcant
increase of ω3-PUFAs EPA and DHA of the total amount of fatty
acids extracted from the heart of both healthy and HF rabbits
(Table 2). The total amount of monounsaturated fatty acids, how-
ever, was signiﬁcantly lower in the ω3-PUFAs fed rabbit hearts
compared to the ω9-MUFAs fed rabbit hearts. Thus, ω3-PUFAs
from the diet were incorporated in the cell membrane at the
expense of monounsaturated fatty acids.
DIETARY ω3-PUFAs DO NOT AFFECT NHE-1 ACTIVITY IN HEALTHY
RABBITS
In a ﬁrst series of experiments, we measured the NHE-1 in
myocytes isolated from healthy rabbits. Body weight after 3 weeks
of diet was similar in ω3-PUFA and ω9-MUFA fed animals
(3.1± 0.2, n = 9) vs. 2.9± 0.2 kg (n = 7), P > 0.05). Figure 2A,
top panel, shows representative recordings of the pHi recovery
after an ammonium prepulse (see Materials and Methods) in a
myocyte isolated from anω3-PUFA andω9-MUFA fed rabbit. The
pHi recovery, and consequently the calculated JNHE-1 (Figure 2A,
bottom panel), was virtually overlapping in the myocytes of ω3-
PUFA and ω9-MUFA fed animals. Figure 2B shows the average
JNHE-1 in the myocytes of ω3-PUFA ω9-MUFA fed animals. The
average JNHE-1 was not signiﬁcantly different in the myocytes of
ω3-PUFA and ω9-MUFA fed animals at any of the pHi’s.
Table 2 | Phospholipid composition of the heart (% of total fat extracted).
Healthy rabbits HF rabbits
ω9-MUFA (n =3) ω3-PUFA (n =5) ω9-MUFA (n =10) ω3-PUFA (n =8)
SATURATED FATTYACIDS
Total 29±3 29±1 23±1 25±1
MONOUNSATURATED FATTYACIDS
Total 31±4 22±2* 23±2 17±1*
C18:1ω9 (oleic acid) 26±4 17±2* 19±2 13±1*
POLYUNSATURATED FATTYACIDS
Total 38±6 47±3 47±1 51±1*
C18:2ω6 (LA) 28±3 28±1 32±1 30±1
C18:3ω3 (ALA) 3.8±0.8 4.0±0.6 2.8±0.5 3.2±0.4
C20:4ω6 (AA) 4.7±3.2 4.6±1.5 8.9±1.2 5.7±0.6
C20:5ω3 (EPA) 0.1±0.1 3.4±1* 0.1±0.1 3.9±0.3*
C22:6ω3 (DHA) 0.3±0.2 4.7±1.4* 0.8±0.2 6.4±0.5*
Unidentiﬁed fatty acids 1.4±0.6 1.4±0.3 7.4±1.1 7.2±0.9
Fatty acid composition expressed as percentage of total fatty acids. ω9-MUFA, high-oleic sunﬂower oil; ω3-PUFA, ﬁsh oil; LA, linoleic acid; ALA, α-linolenic acid;
AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. The sum of listed components is less than the totals indicated here, since not all
components were analyzed. *P<0.05 ω9-MUFA vs. 3-PUFA diet.
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FIGURE 2 | (A)Typical examples of pHi recovery after an ammonium
prepulse (top) and the calculated JNHE-1 (bottom) in an ω9-MUFA and
ω3-PUFA myocyte isolated from healthy animals. (B) Average JNHE-1 in
myocytes of ω9-MUFA and ω3-PUFA fed healthy animals.
DIETARY ω3-PUFAs REDUCES THE NHE-1 ACTIVITY IN A RABBIT
MODEL OF VOLUME- AND PRESSURE-OVERLOAD
In a second series of experiments,we studied the NHE-1 activity in
myocytes isolated from rabbits that underwent model of volume-
and pressure-overload for 4months. Figure 3A, top panel, shows
representative of the pHi recovery after an ammonium prepulse
in a myocyte of an ω3-PUFA and ω9-MUFA fed animal. In the
HF rabbits, pHi recovery after an ammonium prepulse was slower
in the myocyte of the ω3-PUFA animal compared to that in the
myocyte of the ω9-MUFA fed animal. Consequently, the calcu-
lated JNHE-1 was lower in the myocyte of the ω3-PUFA rabbit
(Figure 3A, bottom panel). Figure 3B shows the average JNHE-1 in
myocytes of ω3-PUFAandω9-MUFA fedHFanimals. The average
JNHE-1 was signiﬁcantly lower in myocytes of ω3-PUFA animals
at pH values lower than 7.1 (P < 0.05).
DIETARY ω3-PUFAs OPPOSE THE INCREASE IN NHE-1 ACTIVITY
INDUCED BY HEART FAILURE
In HF animals, but not in healthy animals, NHE-1 activity in
ω3-PUFAs myocytes was signiﬁcantly lower than in ω9-MUFAs
FIGURE 3 | (A)Typical examples of pHi recovery after an ammonium
prepulse (top) and the calculated JNHE-1 (bottom) in an ω9-MUFA and
ω3-PUFA myocyte isolated from rabbit which underwent volume- and
pressure-overload. (B) Average JNHE-1 in myocytes isolated from ω9-MUFA
and ω3-PUFA fed rabbits with volume- and pressure-overload. *P <0.05.
myocytes (Figures 2B and 3B). Previous studies demonstrate that
theNHE-1 activity is signiﬁcantly increased in animal and patients
with HF (Baartscheer et al., 2003a; Chahine et al., 2005; van Bor-
ren et al., 2006). This suggests that dietary ω3-PUFAs suppress
the increase in NHE-1 activity in our rabbit HF model. Figure 4
shows the averages JNHE-1 at pH 7.0 of myocytes of ω3-PUFA and
ω9-MUFA fed healthy and HF animals. HF signiﬁcantly increased
the JNHE-1 in myocytes of ω9-MUFA fed animals (P < 0.05), but
not in myocytes of ω3-PUFA fed animals. Thus, a diet rich in
ω3-PUFAs suppresses the increase in NHE-1 activity associated
with HF.
DIETARY ω3-PUFAs REDUCES THE INCIDENCE OF DADs IN A RABBIT
MODEL OF VOLUME- AND PRESSURE-OVERLOAD
Volume- and pressure-overload in rabbit increased the NHE-1
activity resulting in elevated [Na+]i and secondarily to increased
[Ca2+]i (Baartscheer et al., 2003a). The altered Ca2+ handling
in HF is associated with spontaneous Ca2+ release from the sar-
coplasmic reticulum (SR; Baartscheer et al., 2003b),which activate
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FIGURE 4 | Average JNHE-1 at pH=7.0 of healthy (Ctrl) and HF rabbits fed
ω9-MUFA and ω3-PUFA rich diets. Note that JNHE-1 is increased in the HF
model in ω9-MUFA fed animals, while it was not changed in ω3-PUFA
animals. *P <0.05.
the transient inward current, I ti, resulting in DADs (Verkerk et al.,
2000a). ω3-PUFAs, and not ω9-MUFA, suppress the increase in
NHE-1 activity in our rabbit model of volume- and pressure-
overload. Thus, we hypothesized that the incidence of DADs is
lower in myocytes of ω3-PUFAs fed HF rabbits compared to those
of ω9-MUFA fed HF rabbits. Next, we tested the susceptibility to
induced DADs in HF myocytes by rapid pacing in the presence of
100 nM noradrenalin.
Figure 5A shows typical examples of APs and DAD of myocytes
isolated fromanω3-PUFAand anω9-MUFA fedHFanimal. In the
myocyte of the ω9-MUFA fed HF rabbit, but not in the myocyte
of the ω3-PUFA fed HF rabbit, a DAD (arrow) was present. The
amount of myocytes with more than one DAD was signiﬁcantly
lower (P < 0.05, Fisher’s exact test) in ω3-PUFA fed HF rabbits
compared to those of ω9-MUFA fed HF animal (Table 3). In addi-
tion, the number of DADs was signiﬁcantly lower in the myocytes
of ω3-PUFA fed HF rabbits (Figure 5B). Figure 5C summarizes
the average AP characteristics at 3Hz of myocytes isolated from
ω3-PUFA and an ω9-MUFA fed HF animal in the presence of
100 nM noradrenaline. In presences of 100 nM noradrenaline, no
AP differences were observed between myocytes of ω3-PUFA and
an ω9-MUFA fed HF animal.
HYPERTROPHY IS SIMILAR IN ω3-PUFAs AND ω9-MUFAs FED RABBITS
Various studies demonstrate that ω3-PUFAs suppress develop-
ment of hypertrophy and HF (Takahashi et al., 2005; Duda et al.,
FIGURE 5 | (A)Typical examples of action potentials (AP) and delayed
afterdepolarizations (DADs, arrow). (B) Average number of DADs, (C)
Average AP characteristics. RMP, resting membrane potential; APA, AP
amplitude; dV/dtmax, maximal AP upstroke velocity; APD20, APD50, and,
APD90, AP duration at 20, 50, and 90% repolarization, respectively,
*P <0.05.
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2007; Ramadeen et al., 2010; Chen et al., 2011). Because car-
diac hypertrophy leads to a decrease of the surface to volume
ratio of myocytes, an increased number of NHE-1 proteins are
required to maintain a normal “cytoplasmic” NHE-1 mediated
acid load recovery. The maintained cytoplasmic NHE-1 activity
observed in cardiomyocytes from ω3-PUFAs treated HF rab-
bits (Figure 4) may thus be explained also by a lower degree
of hypertrophy. Therefore, we ﬁnally analyzed important para-
meters for hypertrophy and HF in ω3-PUFA and ω9-MUFA fed
rabbits, which underwent volume- and pressure-overload. Body,
lung, and heart weight were similar in ω3-PUFA and ω9-MUFA
rabbits (Figure 6A). Consequently, relative lung weight and rel-
ative heart weight, an index of cardiac hypertrophy, were not
signiﬁcantly different (Figure 6B). While previously we observed
relative heart weights of 2.2–2.5 in non-failing rabbits with a
standard chow diet (Baartscheer et al., 2003a,b, 2005, 2008; de
Groot et al., 2003; van Borren et al., 2006), the relative heart
weights in the present study of ω3-PUFA and ω9-MUFA fed rab-
bits were 3.6± 0.26 and 3.3± 1.13, respectively. Thus, despite the
absence of differences in degree of hypertrophy, both ω3-PUFA
and ω9-MUFA fed HF rabbit hearts are equally hypertrophied.
Moreover, cell capacitance, an electrophysiological measure of
cell size, was not signiﬁcantly different between myocytes of ω3-
PUFA and ω9-MUFA rabbits (Figure 6C). Furthermore, the pres-
ence of ascites assessed at autopsy was the same in ω3-PUFA
Table 3 | Susceptibility to induce delayed afterdepolarizations (DADs).
Fewer than 1 DAD 1 or more DAD
ω9-MUFA 2 12
ω3-PUFA 7 5
Number of myocytes. Values indicate the number of myocytes having <1 or ≥1
DAD (average of ﬁve tracings). The susceptibility to induce DADs is signiﬁcantly
lower inω3-PUFA compared toω9-MUFAmyocytes (P<0.05, Fisher’s exact test).
and ω9-MUFA rabbits. These data indicate that the degree of
hypertrophy and HF are similar in ω3-PUFA and ω9-MUFA fed
rabbits.
DISCUSSION
OVERVIEW
In this study we examined the effects of dietary ω3-PUFAs on
NHE-1 of myocytes from healthy and failing hearts. In general,
NHE-1 inhibition is thought to be a pharmacological tool for
the treatment of various detrimental cardiac conditions such as
ischemia/reperfusion injury, arrhythmias, hypertrophy, and HF.
In many pre-clinical studies, NHE-1 inhibition has been shown to
reduce ischemia/reperfusion injury (Lee et al., 2005; Ayoub et al.,
2010). In clinical trials, however, the cardioprotective effects of
NHE-1 inhibition were less clear and the treatment with the NHE-
1 inhibitor cariporide was associated with signiﬁcantly greater
incidence of stroke (Fliegel and Karmazyn, 2004). These adverse
effects halted the further use of cariporide as cardioprotective
agent.
Cardiac NHE-1 activity is also signiﬁcantly increased in animal
and patients with HF (Baartscheer et al., 2003a; Chahine et al.,
2005). Pre-clinical studies demonstrated that chronic inhibition
of NHE-1 leads to reversal of cardiac ﬁbrosis, hypertrophy and
HF, and improved contractility in HF models in mice (Engelhardt
et al., 2002), rats (Camillión de Hurtado et al., 2002; Chen et al.,
2004), and rabbit (Baartscheer et al., 2005, 2008). In rabbit studies,
a diet containing theNHE-1 inhibitor cariporide not only reversed
hypertrophy and reduced signs of HF, but also reversed cardiac
ionic and electrical remodeling and prevented changes in myocyte
dimensions, AP duration, and NHE-1 ﬂuxes (Baartscheer et al.,
2005,2008). In addition,Ca2+ homeostasis remainedundisturbed,
and no increase of the incidence of Ca2+ after transient dependent
DADs occurred (Baartscheer et al., 2005). From the prevention of
excessive ﬁbrosis, prolongation of AP duration, and DADs (Nuss
et al., 1999; Marx et al., 2000; Sipido et al., 2000; Janse, 2004;
Pogwizd and Bers, 2004), one may infer that NHE-1 inhibition is
FIGURE 6 | (A) Average body, lung, and heart weight in ω3-PUFA
and ω9-MUFA fed rabbits which underwent volume- and
pressure-overload. n, Number of rabbits (B), Relative lung weight
and relative heart weight, an index of cardiac hypertrophy, in
ω3-PUFA, and ω9-MUFA fed rabbits which underwent volume- and
pressure-overload. (C) Average cell membrane capacitance of
myocytes isolated from ω3-PUFA and ω9-MUFA rabbits. n, Number
of myocytes. *P <0.05.
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also anti-arrhythmic. Thus, at least part of the beneﬁcial effects of
ω3-PUFAs may be attributed to NHE-1 inhibition during HF.
DIETARY ω3-PUFAs DO NOT SUPPRESS THE NHE-1 IN MYOCYTES OF
HEALTHY ANIMALS
In myocytes isolated from healthy animals, we found that ω3-
PUFAs do not affect the NHE-1 activity as compared to ω9-
MUFAs (Figure 2). Our results contrast with a study by Goel
et al. (2002) that showed that ω3-PUFAs reduced the NHE-1
activity. This discrepancy is likely due to study design. We stud-
ied dietary ω3-PUFAs intake that causes ω3-PUFA incorporation
into cardiac cell membranes (Owen et al., 2004), whereas Goel
et al. (2002) studied direct application of ω3-PUFAs on cardiac
myocytes.Acutely appliedω3-PUFAs and incorporatedω3-PUFAs
have different effects on cardiac electrophysiology (den Ruijter
et al., 2007, 2010; Verkerk et al., 2009), and our study suggests that
it also has a different effect on pHi. Dietary ω3-PUFAs intake does
not affect the resting pHi in healthy animals (present study), while
acute administration resulted in acidosis (Aires et al., 2003), which
could well explain the lower apparent NHE-1 activity observed by
Goel et al. Other explanations may be the differences in species
(pig vs. rabbit) and the technique used to measure NHE-1 activ-
ity (radioactive Na+ uptake in cell suspensions vs. single cell
ﬂuorescence).
DIETARY ω3-PUFAs SUPPRESS NHE-1 UPREGULATION IN A RABBIT
MODEL OF VOLUME- AND PRESSURE-OVERLOAD
In our rabbit model of volume- and pressure-overload, we found
that the NHE-1 activity in ω3-PUFAs myocytes was signiﬁcantly
lower than in ω9-MUFAs myocytes (Figure 3). The mechanisms
for the lower NHE-1 activity are unknown. One may speculate
that ω3-PUFAs affect membrane ﬂuidity (Jahangiri et al., 2000),
resulting in a decrease of NHE-1 activity (Bookstein et al., 1997).
This membrane ﬂuidity theory is frequently used to explain the
effects of ω3-PUFAs on membrane channels, however, but the lack
of signiﬁcant effects of ω3-PUFAs on NHE-1 in healthy animals is
not in line of this hypothesis.
A second hypothesis is that ω3-PUFAs attenuate cardiac hyper-
trophy (Takahashi et al., 2005; Duda et al., 2007; Ramadeen et al.,
2010; Chen et al., 2011), resulting in a decrease of NHE-1 activity
(Baartscheer et al., 2005). In the present study,however, the relative
heart weight and cell capacitance,both indices of cardiac hypertro-
phy, did not differ between ω3-PUFAs and ω9-MUFAs fed rabbits
or their myocytes, respectively (Figure 6). This excludes differ-
ences in hypertrophy as a likely mechanism. The unaltered degree
of hypertrophy is in contrast with observations in mice with trans-
verse aortic constriction (Chen et al., 2011) and juvenile visceral
steatosis (Takahashi et al., 2005), rats with abdominal aortic band-
ing (Duda et al., 2007), and rapid-paced dogs (Ramadeen et al.,
2010) where dietary supplementation of ω3-PUFAs attenuated
cardiac hypertrophy. This discrepancy may be explained by differ-
ences in HF model, species, ω3-PUFAs concentration, but also to
the control diets used. In our study, the control (ω9-MUFAs) diet
was supplemented with HOSF, while in the other studies the con-
trol diet was standard chow or supplemented with corn oil. The
importance of a proper control diet is supported by the ﬁnding
that the relative heart weight of ω9-MUFAs fed HF rabbits was
≈3.6 (Figure 6), while in the same rabbit HF model with a stan-
dard chow diet we previously measured relative heart weights of
4.4–6.0 in our laboratory (Baartscheer et al., 2003a,b, 2005, 2008;
de Groot et al., 2003; van Borren et al., 2006; den Ruijter et al.,
2008). This suggests that both ω3-PUFAs and ω9-MUFAs diets
reduce the degree of hypertrophy. Further studies are required to
address this.
A third hypothesis is that dietary ω3-PUFAs affect cell signal-
ing and enzymes important for NHE-1 activity. The NHE is not
only activated bypHi but also by anumber of other stimuli.NHE-1
activity is accelerated in response of endothelin, angiotensin II, and
G protein and second messenger stimulation of PKC (diacylglyc-
erol) and PKA (forskolin,β1-adrenoreceptor agonists; Kandasamy
et al., 1995; Karmazyn et al., 2001;Díaz et al., 2010). Also,mitogen-
activated protein (MAP) kinase-dependent pathways result in the
phosphorylation of the NHE (Sartori et al., 1999). ω3-PUFAs
affect several of these NHE-1 stimuli. They reduce diacylglycerol
and PKC, activate the parasympathetic nervous system, and reduce
angiotensin-converting enzyme (ACE) activity (Mohan and Das,
2001; Seung-Kim et al., 2001; Takahashi et al., 2005), although the
latter is not a consistent ﬁnding (Ogawa et al., 2009). An intriguing
question is why the NHE-1 activity in myocytes of ω3-PUFA fed
animals is lower than in myocytes of ω9-MUFA fed animals in our
model of volume- and pressure-overload, while it is not differ-
ent in healthy rabbits. This suggests that the NHE-1 reduction is
due to changes in cell signaling pathways active during HF (Ono-
hara et al., 2006; Niizeki et al., 2008). One can speculate that the
lower NHE-1 activity also reduces the degree of hypertrophy and
HF, but this was not observed in the present study, suggesting that
NHE-1 is more sensitive for ω3-PUFAs modulation of cellular sig-
naling pathways than hypertrophy and HF. Alternatively, the time
required for hypertrophy andHF attenuationmight be longer than
that for NHE-1 reduction. The decreased NHE-1 activity may also
be the result of a decreased expression of NHE-1.
DIETARY ω3-PUFAs SUPPRESS DADs
In our HF model of volume-and pressure-overload, we observed
that the susceptibility for DAD development was signiﬁcantly
lower in myocytes of ω3-PUFAs fed rabbits compared to those
of ω9-MUFAs fed rabbits (Table 3; Figure 6B). DADs occur in
[Ca2+]i overload condition (Verkerk et al., 2000a, and primary ref-
erences cited therein). Thus, our results indicate that myocytes of
ω3-PUFAs fed failing rabbits are less sensitive for [Ca2+]i overload
development than those of ω 9-MUFAs fed failing rabbits. Accord-
ing to the importance of the NHE-1 for [Ca2+]i (Baartscheer et al.,
2003a), it is tempting to speculate that this is due to the lowerNHE-
1 activity in myocytes of ω3-PUFAs fed HF rabbits. Previously we
observed multiple changes in ionic currents due to dietary and
acute ω3-PUFAs resulting in AP shortening (Verkerk et al., 2006)
and reduced susceptibility of early afterdepolarizations and DADs
development (den Ruijter et al., 2006, 2008; Berecki et al., 2007).
Dietary ω3-PUFAs caused an increase of IK1 resulting in a
more stable RMP (Verkerk et al., 2006). The latter will result
in smaller DAD amplitudes. In addition, dietary ω3-PUFAs
decreased INCX (Verkerk et al., 2006), which carries the tran-
sient inward current, I ti, responsible for DADs (Verkerk et al.,
2000a, and primary references cited therein). Decreased INCX
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may therefore also result in DADs of smaller amplitude. How-
ever, while both changes may reduce the DAD amplitude, they
will not reduce the propensity to spontaneous Ca2+ release of
the SR and thus DADs. Previously, we observed AP shortening
due to dietary ω3-PUFAs (Verkerk et al., 2006). AP shortening
leads to an increased diastolic interval, favoring removal of excess
Ca2+ from the cytosol. This will reduce [Ca2+]i overload con-
ditions and DAD occurrence (Verkerk et al., 2000b, and primary
refs. cited therein). However, in presence of 100 nM noradrena-
line, AP duration did not differed signiﬁcantly between myocytes
of ω3-PUFAs and ω9-MUFAs fed HF rabbits (Figure 5C). Thus,
in the present study the role of AP duration in susceptibility
of DADs is limited, although this cannot be entirely excluded
in the absence of data on intracellular calcium and sodium
activity.
CONCLUSION
Dietary ω3-PUFAs from FO suppress upregulation of the NHE-1
activity in a rabbit model of volume- and pressure-overload. The
degree of hypertrophy and HF is similar in myocytes of ω3-PUFAs
and ω9-MUFAs fed HF rabbits, but the lower NHE-1 activity
in myocytes of ω3-PUFAs fed HF rabbits suggests that dietary
ω3-PUFAs administration during the development of HF may be
anti-arrhythmic via reduction of ischemia/reperfusion injury and
Ca2+-modulated arrhythmias.
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